Evaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer Therapy

• Xiaolu Wei ,

  Contributed equally to this work with: Xiaolu Wei, Nan Si

  Affiliation Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing, China

  ⨯
• Nan Si ,

  Contributed equally to this work with: Xiaolu Wei, Nan Si

  Affiliation Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing, China

  ⨯
• Yuefei Zhang,

  Affiliation China Resources Sanjiu Pharmaceutical Co., Ltd, Shenzhen, Guangdong Province, China

  ⨯
• Haiyu Zhao,

  Affiliation Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing, China

  ⨯
• Jian Yang,

  Affiliation Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing, China

  ⨯
• Hongjie Wang,

  Affiliation Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing, China

  ⨯
• Lianmei Wang,

  Affiliation Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing, China

  ⨯
• Linyu Han,

  Affiliation Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing, China

  ⨯
• Baolin Bian

  * E-mail: baolinbian2376@163.com

  Affiliation Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences, Beijing, China

  ⨯